期刊文献+

慢性HBV感染ALT持续正常与肝损伤的关系及其相关因素分析 被引量:3

Association between persistent normal ALT with chronic hepatitis B and liver injure as well as analysis of correlated factors
下载PDF
导出
摘要 目的评估ALT持续正常的慢性HBV感染者(PNA)的肝脏损伤情况,探讨与其损伤相关的因素,为临床正确及时处理此类患者提供参考。方法对符合研究标准的160名慢乙肝患者,包括血清ALT水平持续正常的53例患者,按ALT水平分成4组,检测相关生化免疫等指标,同时做肝病理穿刺,分析与肝损伤相关的因素。结果37.7%的PNA患者有S2及以上等级的纤维化,45.3%的PNA患者有G2及以上等级的炎症水平。年龄越大,ALT水平越高,更高水平的HBVDNA载量,有更严重的肝损伤。结论53例PNA患者中,43.4%有明显纤维化或明显炎症,对于PNA的慢乙肝患者,大于40岁、ALT>25u/L、HBVDNA定量>104/mL,尤其是男性患者,应考虑肝穿刺以证实是否有肝损伤。 Purpose To assess liver injury of these patients with chronic hepatitis B whose ALT are persistently normal, to explore these factors associated with liver injury, and to provide choices when clinicians are treating those patients. Methods 160 patients meeting our inclusion criteria were divided into four groups ac- cording to their ALT. Multiply clinical, biochemical, immunological, virological indexes were collected, meanwhile, liver biopsy was performed. Results 43.4 % of patients with PNA have significant inflammation and 17.1% has significant fibrosis. Older age, higher ALT and HBV DNA load predicted liver injury. Conclusion In our studies, 45.3 % of patients with PNA were associated with severe inflammation or fibrosis. We can make a conclusion that liver biopsy should be performed in those patients whose age 〉 40 y, ALT 〉 25 u/ L, HBV DNA 〉 10^4 to confirm whether hepatic injury exists.
作者 张岱 王念跃
出处 《中国生化药物杂志》 CAS CSCD 2008年第5期342-344,共3页 Chinese Journal of Biochemical Pharmaceutics
基金 南京市医药卫生科研课题(YKK05130)
关键词 慢性HBV感染 A岍持续正常 肝损伤 chronic hepatitis B persistent normal ALT liver injures
  • 相关文献

参考文献7

二级参考文献31

  • 1中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[J].传染病信息,2005,18(z1):1-12. 被引量:467
  • 2田琦琦,贾克明.乙型肝炎病毒基因前C区变异的动态观察[J].中华内科杂志,1995,34(4):232-234. 被引量:28
  • 3赵桂鸣,邹焕文.乙肝病毒携带者肝组织学的改变[J].天津医药,2005,33(9):550-551. 被引量:25
  • 4邢汉前,辛绍杰,张欣,陈黎明,赵景民,游绍莉,赵军,王岩.慢性乙型肝炎病毒感染免疫耐受期患者的临床病理特征[J].世界华人消化杂志,2006,14(14):1425-1429. 被引量:28
  • 5王平忠 周永兴 等.乙肝病毒定量检测及意义.中华医学会第十次全国病毒性肝炎及肝病学术会议论文汇编[M].西安,2000,9.194.
  • 6谢志萍 沙安莉.慢性乙型肝炎患者HBVVDNA水平与临床关系.中华医学会第十次全国病毒性肝炎及肝病学术会议论文集汇编[M].西安,2000,9.146.
  • 7[2]骆抗先.乙型肝炎基础和临床,第二版.北京:人民卫生出版社,2001:117~120
  • 8[6]Sato S, Suzuki K, Akakane Y, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant Hepatitis.Ann Intern Med, 1995,122:241 ~ 248
  • 9[2]Yim HJ,Lok AS.Natural history of chronic hepatitis B virus i nfection:What we knew in 1981 and what we know in 2005[J].Hepatology,2006,43:S173-S181.
  • 10[4]Lau GK,Nanji A,Hou J,et al.Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune tolerant phase[J].J Viral Hepat,2002,9:280-287.

共引文献14239

同被引文献22

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部